ZBIO
Zenas BioPharma, Inc.
28.70
+0.12 (+0.42%)
52w low 13.50
44.60 high
48.9% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 50.00M | 5.00M | 10.00M | |
| Operating Expenses | 75.20M | 77.15M | 168.89M | 221.38M | |
| R&D | 61.69M | 60.03M | 139.14M | 168.06M | |
| SG&A | 13.51M | 17.11M | 29.75M | 53.32M | |
| Operating Income | -75.20M | -27.15M | -163.89M | -211.38M | |
| EBITDA | -75.12M | -27.03M | -156.42M | -370.43M | |
| Pretax Income | -119.28M | -36.82M | -156.56M | -377.82M | |
| Income Tax | 0.00 | 301.00K | 429.00K | -79.00K | |
| Net Income | -119.28M | -37.12M | -156.99M | -377.74M | |
| EPS Diluted | -9.26 | -2.13 | -11.89 | -8.44 | |
| Diluted Shares | 12.88M | 17.42M | 13.20M | 44.73M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+100.0%